Andrew E. Gelman, PhD

Andrew E. Gelman, PhD

Jacqueline G. and William E. Maritz Endowed Chair in Immunology and Oncology
Section of Thoracic Surgery
Division of Cardiothoracic Surgery
Chief, Section of Transplant & Immunology Research
Division of Surgical Sciences

Specialties

  • Lung transplantation immunology 

Meet Dr. Gelman 

Dr. Andrew Gelman is an accomplished transplant immunologist whose work focuses on investigating the mechanisms that control lung allograft tolerance. 

His research has been funded by multiple grants from the National Institutes of Health, and in 2018 he was named the Jacqueline G. and William E. Maritz Endowed Chair in Immunology and Oncology—a professorship meant to drive innovative research in lung disease. 

Dr. Gelman studied biochemistry at the University of California, Los Angeles, and earned his doctorate in molecular and cellular immunology from the University of Pennsylvania School of Medicine.  

Dr. Gelman also serves as chief of the Section of Transplant & Immunology Research within the Division of Surgical Sciences. 

Our research aims to achieve new discoveries that will set the stage for developing novel therapeutic strategies to improve the success of lung transplants.

Dr. Gelman

Degrees

Doctor of Molecular and Cellular Immunology 
University of Pennsylvania School of Medicine, Philadelphia, PA 
2006 


Research interests

Our laboratory is actively pursuing the mechanisms that control lung allograft tolerance. We have 4 main areas of interest. (1) How ischemia reperfusion injury regulates lung allograft survival (2) The role of pattern recognition receptors in lung allograft rejection (3) How lung allografts regulate bone marrow myelopoiesis (4) The role of secondary lymphoid organs in lung transplantation 

Thoracic Immunobiology Lab >>

Board certifications

  • List

Dr. Gelman in the news